Li, Danni
Zhang, Qiying
Zhou, Yuzhu
Zhu, Hua
Li, Tong
Du, Fangkai
Funding for this research was provided by:
Guangxi Natural Science Foundation (2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021, 2017GXNSFBA198021)
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine ((2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32, (2014) No.32)
Collaborative Innovation Center of Zhuang and Yao EthnicMedicine ((2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20, (2013) No.20)
Guangxi University for Nationalities Key Laboratory of National Medicine (No, No, No, No, No, No)
Natural Science Foundation of China (No.11904059, No.11904059, No.11904059, No.11904059, No.11904059, No.11904059)
Article History
Received: 23 March 2022
Accepted: 4 July 2022
First Online: 12 July 2022
Declarations
:
: This study was approved by Ethics Committee of Guangxi University for Chinese medicine, all procedures reporting in this study on the animals were carried in accordance with the ARRIVE guidelines, and the study was carried out in accordance with the relevant guidelines and regulations. Huh 7 human hepatocellular carcinoma line and normal hepatocyte cell L-02 cells did not require ethics approval for their use. Informed consent was therefore not applicable.
: Not applicable.
: The authors declare that they have no competing interests.